Senior Director, HEOR/RWE GI
Revolution Medicines
About this role
Revolution Medicines is a clinical-stage oncology company focused on developing targeted therapies for RAS-addicted cancers. They are seeking a Senior Director, HEOR/RWE to develop strategies and execute plans to demonstrate the value of their cancer treatments to healthcare organizations and stakeholders.
Skills
About Revolution Medicines
revmed.comIndustry
Healthcare
Revolution Medicines (RevMed) is a biopharmaceutical company dedicated to discovering, developing, and delivering novel targeted medicines for patients with cancer. Their mission focuses specifically on "revolutionizing treatment for patients with RAS‑addicted cancers" through precision-targeted therapies. The company emphasizes a science-driven, end-to-end approach from discovery to delivery. RevMed brands its team as "Revolutionaries" committed to transforming outcomes for people with RAS‑driven tumors.
Recent company news
Victory Capital Management Inc. Trims Stock Holdings in Revolution Medicines, Inc. $RVMD
13 hours ago
Revolution Medicines Trials, Funding Capacity And Insider Moves Shape Risk Outlook
5 days ago
Revolution Medicines Reports Fourth Quarter and Full Year 2025 Financial Results and Update on Corporate Progress
2 weeks ago
Revolution Medicines, Inc. (RVMD) Net Loss Widens amid Progress on Clinical Trial Programs
1 week ago
AbbVie denies media reports of talks to buy Revolution Medicines
Jan 7, 2026
About Revolution Medicines
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Revolution Medicines.
Salary
$244k – $305k
per year
More jobs at Revolution Medicines
Similar Jobs
Associate Director, US HEOR & RWE (Remote-Based)
Eisai
Senior Director, Health Economics & Outcomes Research
Ipsen
Director, Global HEOR - Oncology
0468 BMS Polska Sp. z o.o.
Director, Global Health Economic & Outcomes Research / Real World Evidence (HEOR/RWE lead – BTK Degrader)
BeOne Medicines
Global HEOR Director- CDI - F/M
Pierre Fabre Group
Director, HEVA (HEOR) Business Partner
Sanofi